Ind-Swift Laboratories Limited has informed the Exchange about Disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mauritius-based fund Zeal Global Opportunities Fund has acquired 24,68,000 equity shares of Ind-Swift Laboratories, representing 3.67% of the company's paid-up share capital. The acquisition was made through the conversion of warrants into equity shares under a preferential allotment, rather than an open market purchase. With this conversion, Zeal Global's total stake in the company has risen from 2.53% to 5.95%, crossing the 5% disclosure threshold. The acquirer does not belong to the promoter/promoter group. As a result of this conversion, Ind-Swift's equity share capital has expanded from Rs. 60.62 crore to Rs. 67.21 crore (from 6.06 crore shares to 6.72 crore shares).
A foreign fund has crossed the 5% ownership threshold, which is a positive signal of institutional interest, though it comes at the cost of dilution for existing shareholders (share count rose by ~10.9%). No fresh cash flows into the company as these shares came via warrant conversion already agreed upon earlier. Stock price impact is likely neutral to mildly positive depending on further actions by the fund.